South Africa’s ongoing foot-and-mouth disease (FMD) outbreak, which has disrupted livestock farming and exports since 2024, has prompted urgent efforts to secure vaccines. A controversy has emerged over the procurement of Bioaftogen, a vaccine produced by Argentina’s Biogénesis Bagó.
